Testing effectiveness (Phase 2)Looking for participantsNCT06769295
What this trial is testing
A Phase II Study of AK112 (PD1/VEGF Bispecific) in Combination with Chemotherapy in Patients with NSCLC
Who this might be right for
Lung Cancer, Non-Small Cell
Sichuan University 28